Keywords: Placenta, Quantitative Imaging, R2* mapping, Biomarkers, Contrast Agents, Ferumoxytol
Motivation: Pregnancy complications are often associated with placenta dysfunction, which lacks non-invasive assessment in early pregnancy.
Goal(s): Evaluating placental R2* as a non-invasive and quantitative biomarker to identify and monitor pregnancy complications.
Approach: We introduce a novel thrombotic and inflammatory placental injury model of rhesus macaques and report mean values, histograms, and spatial distribution of placental R2* based on blood oxygenation level dependent (BOLD) MR imaging at different gestational ages before and after iron nanoparticle (ferumoxytol) administration.
Results: Higher overtime and post-contrast increase in mean values and more heterogeneous spatial patterns of R2* are observed in placentas with induced injury.
Impact: A refined nonhuman primate model for thrombosis and inflammation is introduced for investigating placental pathology. Larger R2* increases over time and immediately after ferumoxytol injections suggest the potential for R2* to be an indicator of pathology with or without contrast.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords